ATE174963T1 - Klonierung und expression eines rhoptry- assoziierten proteins aus p. falciparum - Google Patents

Klonierung und expression eines rhoptry- assoziierten proteins aus p. falciparum

Info

Publication number
ATE174963T1
ATE174963T1 AT91913838T AT91913838T ATE174963T1 AT E174963 T1 ATE174963 T1 AT E174963T1 AT 91913838 T AT91913838 T AT 91913838T AT 91913838 T AT91913838 T AT 91913838T AT E174963 T1 ATE174963 T1 AT E174963T1
Authority
AT
Austria
Prior art keywords
pct
falciparum
expression
associated protein
rhoptry
Prior art date
Application number
AT91913838T
Other languages
English (en)
Inventor
Allan James Saul
Juan Anton Cooper
David Owen Irving
Original Assignee
Saramane Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Saramane Pty Ltd filed Critical Saramane Pty Ltd
Application granted granted Critical
Publication of ATE174963T1 publication Critical patent/ATE174963T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C07K16/205—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT91913838T 1990-08-02 1991-08-01 Klonierung und expression eines rhoptry- assoziierten proteins aus p. falciparum ATE174963T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPK152590 1990-08-02

Publications (1)

Publication Number Publication Date
ATE174963T1 true ATE174963T1 (de) 1999-01-15

Family

ID=3774860

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91913838T ATE174963T1 (de) 1990-08-02 1991-08-01 Klonierung und expression eines rhoptry- assoziierten proteins aus p. falciparum

Country Status (10)

Country Link
US (1) US5573943A (de)
EP (1) EP0541629B1 (de)
JP (1) JPH05508996A (de)
AT (1) ATE174963T1 (de)
CA (1) CA2088478C (de)
DE (1) DE69130675T2 (de)
IL (1) IL99034A (de)
MY (1) MY107451A (de)
WO (1) WO1992002623A1 (de)
ZA (1) ZA916106B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040013671A1 (en) * 2000-05-31 2004-01-22 Institut Pasteur Antibodies which bind to proteins involved in cyttoadhesion of Plasmodlum falciparum ring-stage-infected erythrocytes
CA2410051A1 (en) * 2000-05-31 2001-12-06 Institut Pasteur Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes
US20040082048A1 (en) * 2002-10-15 2004-04-29 Viswanath Nittala Venkata Narasimha Genes and protein sequences useful as drug targets for therapeutic action against protozoa
WO2008055254A2 (en) * 2006-11-01 2008-05-08 Board Of Regents, The University Of Texas System Formulations and methods for oral delivery of proteins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81026A0 (en) * 1985-12-24 1987-03-31 Inst Medical W & E Hall Peptides for immunizing against plasmodium falciparum,dna molecules coding for them and compositions containing said peptides
ZA888983B (en) * 1987-12-01 1989-08-30 Saramane Pty Ltd Rhoptry antigen of plasmodium falciparum

Also Published As

Publication number Publication date
EP0541629A1 (de) 1993-05-19
EP0541629A4 (en) 1993-12-29
CA2088478A1 (en) 1992-02-03
US5573943A (en) 1996-11-12
MY107451A (en) 1995-12-31
DE69130675T2 (de) 1999-10-14
JPH05508996A (ja) 1993-12-16
EP0541629B1 (de) 1998-12-23
WO1992002623A1 (en) 1992-02-20
ZA916106B (en) 1992-06-24
DE69130675D1 (de) 1999-02-04
IL99034A (en) 1996-10-16
CA2088478C (en) 2002-06-11

Similar Documents

Publication Publication Date Title
ES2044950T3 (es) Un procedimiento para producir una proteina.
DE69838143D1 (de) Antimikrobielle peptide
NO964650L (no) LAG-3 proteinopploselige polypeptidfraksjoner, fremgangsmate for fremstilling, terapeutisk preparat og anti-idiotype antistoff
DE60141546D1 (de) Polypeptide enthaltend extrazellulären Domäne von IL-20RA und/oderr IL-20RB
ATE215124T1 (de) Rekombinante tetc-fusionsprotein enthaltene impfstoffzusammensetzungen
ATE292685T1 (de) Herstellung und verwendung von rekombinanten influenza a virus m2 konstruktionen und impstoffe
DK0737207T3 (da) Inhibitorer for humant plasmin afledt af Kunitz-domæner
ATE417275T1 (de) Puffern zur stabilizierung von hcv antigenen
DE69333673D1 (de) Epitope von Stress Proteinen
HUP0104468A2 (hu) Elkülönített dimer fibroblaszt aktivációs alfa-protein és alkalmazása
ES2144399T3 (es) Clonado del adn de virus de anemia de los pollos.
ATE175119T1 (de) Vakzine gegen immunodefizienz-virus der katze (kiv)
DE69331501D1 (de) Unterdrückung der Proliferation von T-Zellen mittels Peptidfragmenten des basischen Proteins aus Myelin
DK0434605T3 (da) Ny fremgangsmåde til fremstilling af ikke-fusioneret protein i E.coli
DE3751727D1 (de) Polypeptide zur verwendung bei der diagnose von mycoplasmainfektionen bei schweinen, sowie rekombinant-dns-verfahren zur herstellung derselben
ATE174963T1 (de) Klonierung und expression eines rhoptry- assoziierten proteins aus p. falciparum
FR2692282B1 (fr) Clonage du gene codant pour la proteine gp28.5 de t. gondii; fragments peptidiques issus de ladite proteine et leurs applications.
NO970113D0 (no) Kollagenbindende protein eller polypeptid
DE59108261D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
DE69017352D1 (de) An HIV relatierte Peptide.
DE69012989D1 (de) Peptiden von retinblastoma gen produkten und antikoerper dagegen.
DE69534738D1 (de) Leukocyten-aktivierender Faktor
DK128687D0 (da) Proteiner samt deres fremstilling og anvendelse
DE69128904D1 (de) Expressionskassette eines Vorläufers von Endothiapepsine in Cryphonectria parasitica
KR910001051A (ko) 결실형 알파 아밀라제

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties